CVE-2026-21974 json
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).
published 2026-01-20 9 mo ago modified 2026-06-17 4 mo ago also EUVD-2026-3538
- cvss
- 5.3
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 17%
- public exploits
- 0
- none known
Summary
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
CISA SSVC
- Exploitation
- none
- Automatable
- yes
- Technical impact
- partial
- Assessed
- 9 mo ago
Exploit prediction
0.26% chance of exploitation in the next 30 days, higher than 17% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 5.3 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N |
Affected products
- Oracle Corporation Oracle Life Sciences Central Designer
Classification
- Weakness
-
- CWE-200 Exposure of Sensitive Information to an Unauthorized Actor
References
-
oracle.com
/security-alerts/cpujan2026.html
vendor-advisory
Sources
- CVE List CVE-2026-21974
- NVD CVE-2026-21974
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.